4//SEC Filing
Martin Samuel Bates 4
Accession 0001415889-24-000592
CIK 0000744218other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:05 PM ET
Size
7.1 KB
Accession
0001415889-24-000592
Insider Transaction Report
Form 4
Martin Samuel Bates
SVP AND CFO
Transactions
- Exercise/Conversion
Common Stock
2024-01-02$2.78/sh+10,750$29,885→ 35,128 total - Exercise/Conversion
Incentive Stock Option (Right to Buy)
2024-01-02−10,750→ 0 totalExercise: $2.78Exp: 2029-06-19→ Common Stock (10,750 underlying)
Footnotes (1)
- [F1]As of June 19, 2023, the option is fully vested.
Documents
Issuer
Celldex Therapeutics, Inc.
CIK 0000744218
Entity typeother
Related Parties
1- filerCIK 0001709024
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:05 PM ET
- Size
- 7.1 KB